Relation Between Genetic Factors and Frailty in Older Adults.

Autores de INCLIVA

• 

  Marta Inglés De La Torre

  Autor

• 

  Cristina Mas Bargues

  Autor

• Lucia Gimeno Mallench

  Autor

• 

  Juan Gambini Buchon

  Autor

• 

  Consuelo Borras Blasco

  Autor

• 

  Jose Viña Ribes

  Autor

Participantes ajenos a INCLIVA

• Cruz-Guerrero, Raquel
• Garcia-Garcia, Francisco J
• Rodriguez-Manas, Leocadio

Grupos y Plataformas de I+D+i

• Grupo de investigación en envejecimiento y ejercicio físico

  

  Leading Researcher

  Jose Viña Ribes

Abstract

Objectives: Frailty is a geriatric syndrome that identifies individuals at higher risk of disability, institutionalization, and death. We previously reported that frailty is related to oxidative stress and cognitive impairment-related biomarkers. The aim of this study was to determine whether frailty is associated with genetic variants. Design: Longitudinal population-based cohort of 2488 community-dwelling people from Toledo, Spain, aged 65 years or older. Setting and participants: We obtained blood samples from 78 individuals with frailty and 74 nonfrail individuals who were nonfrail (according to Fried criteria) from the Toledo Study of Healthy Ageing and extracted DNA using the Chemagic DNA blood kit. Measures: Sample genotyping was carried out by means of Axiom Exome 319 Genotyping Array (Thermo Fisher Scientific), which contains 295,988 markers [single-nucleotide polymorphisms (SNPs) and rare variants], and transferred to the GeneTitan Instrument (Affymetrix). Results: We found 15 SNPs (P <.001), 18 genes (P <.005), and 4 pathways (P <.05) related to cytokine-cytokine receptor interaction, natural killer cell-mediated cytotoxicity, regulation of autophagy, and renin-angiotensin system as the most strongly associated with frailty. Conclusions/Implications: The specific genetic features related to energy metabolism, biological processes regulation, cognition, and inflammation highlighted by this preliminary analysis offer useful insights for finding biologically meaningful biomarkers of frailty that allow early diagnosis and treatment. Further research is needed to confirm our novel findings in a larger population. Indeed, the EU-funded FRAI-LOMICS research effort will address this question. (C) 2019 AMDA - The Society for Post-Acute and Long-Term Care Medicine.

© 2019 AMDA - The Society for Post-Acute and Long-Term Care Medicine.

Keywords

• Frailty; SNPs; genetic variants; biomarkers